NPI registry status
Active
2026 NPPES data Ophthalmology Physician NPI 1649477860 MD
Verify on CMS → Paul Riske, MD
Ophthalmology Physician in Raleigh, North Carolina.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 22,388 in Ophthalmology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
745
Medicare Part D claims · 471 beneficiaries · Ophthalmology Physician avg: 1K
Generic prescribing
96%
generic claims · 4% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
83.1/100
▼ 0 pts below national avg 83.5 · Above neutral
Industry payments
$161.68
3 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Paul Riske, MD reported a CMS MIPS final score of 83.1/100 - below the 83.5 national average - and filed 745 Medicare Part D claims in 2024.
- 83.1/100
- MIPS score · 0 vs avg
- 745
- Part D claims, 2024
- 96%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Paul Riske, MD
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1649477860), first enumerated 06/29/2007.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 745 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 83.1/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$161.68 in reported industry payments (3 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1649477860 · Ophthalmology Physician
NPI-10 · ENUM-MID · TAX-MID · MIPS-INLINE · RX-LIGHT · BOOK-LIGHT · PHOTO-FINISH
- NPI-10 1649477860
- ENUM-MID 2007
- TAX-MID 22K Ophthalmology Physician
- MIPS-INLINE 83.1/100
- RX-LIGHT 745
- BOOK-LIGHT 622 in North Carolina
- PHOTO-FINISH James Constans, M.D. · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Riske · this pro…
Riske · this provider
83.1 MIPS pts
- Gary Markowitz, …
Gary Markowitz, MD
83.1 MIPS pts
- James Constans, …
James Constans, M.D.
83.1 MIPS pts
- Daniel Ahn, MD ·…
Daniel Ahn, MD
83.1 MIPS pts
- Sungjun Hwang, M…
Sungjun Hwang, M.D.
83.1 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Paul Riske, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
83 ≥ 39th percentile 39% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Paul Riske, MD sits
This provider among ophthalmology physician peers
Across the 8,767 ophthalmology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Paul Riske, MD writes more Part D claims than 37% of them and scores higher on MIPS quality than 34% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one ophthalmology physician peer from a representative sample of 60; the gold marker is Paul Riske, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Paul Riske, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Paul Riske, MD?
Near national averagePrimary specialty
Ophthalmology Physician
Medicare Part D claims
745 50% vs specialty avg
MIPS final score
83.1/100 0.4 pts vs avg
Specialty distribution in North Carolina
How Ophthalmology Physician compares to other specialties among North Carolina providers
Medicare quality performance, MIPS
Paul Riske, MD's 2023 MIPS final score plotted against the Ophthalmology Physician national average
- MIPS Final Score
- 83.1/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1649477860 |
|---|---|
| Specialty | Ophthalmology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 06/29/2007 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
83.088
Final Score
Measured-score avg: 83.5
100
Quality
49.46
Cost
93
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where Paul Riske, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Raleigh Ophthalmology PC
Raleigh, NC
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Paul Riske, MD. Source: openpaymentsdata.cms.gov.
Total received
$162
Largest payer
ABBVIE INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Generic-heavy
Paul Riske, MD - brand share 4.0%
Ophthalmology Physician average
4% brand-name claims vs 96% generic, on 745 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
745
Total Claims
$17K
Total Drug Cost
471
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 816.967
- Total Day Supply
- 12,937
- Brand vs Generic
- 4% brand / 96% generic
- Brand Drug Cost
- $9K
- Generic Drug Cost
- $9K
- Opioid Claims
- 24 (3.2% rate)
- Antibiotic Claims
- 68
Patient Demographics
- Average Patient Age
- 75.0 years
- Avg HCC Risk Score
- 1.06
- Gender Split
- 69% female / 31% male
- Age Distribution
- <65: 20, 65-74: 200, 75-84: 204, 85+: 47
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Paul Riske, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Erythromycin
Erythromycin
260 claims
- Neomycin-Polymyxin…
Neomycin-Polymyxin-Dexameth
168 claims
- Moxifloxacin 76
Moxifloxacin
76 claims
- Doxycycline Hyclate 37
Doxycycline Hyclate
37 claims
- Cephalexin 26
Cephalexin
26 claims
- Prednisone 23
Prednisone
23 claims
- Tramadol Hcl 22
Tramadol Hcl
22 claims
- Fluticasone Propio… 15
Fluticasone Propionate
15 claims
| Drug | Claims |
|---|---|
| Erythromycin Erythromycin Base | 260 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 168 |
| Moxifloxacin Moxifloxacin Hcl | 76 |
| Doxycycline Hyclate | 37 |
| Cephalexin | 26 |
| Prednisone | 23 |
| Tramadol Hcl | 22 |
| Fluticasone Propionate | 15 |
| Latanoprost | 14 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 14 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Ophthalmology Physician Overview
How Paul Riske, MD fits within the Ophthalmology Physician landscape nationally.
22,388
Ophthalmology Physician Providers in US
56
States with Ophthalmology Physician
1,490
Avg Claims per Provider
Paul Riske, MD's 745 claims are below the specialty average of 1,490.
Nationwide Ophthalmology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Riske, both outside North Carolina so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (83.1 here).
Same NPPES enumeration year (2007)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Ophthalmology Physician Providers in North Carolina
Other clinicians with the same primary specialty enrolled in North Carolina, drawn from the same CMS NPPES roster as Riske.
One of 622 Ophthalmology Physician providers enrolled in North Carolina, 5 are shown here.
Dr. Brian Adair
M.D.
Hickory, NC
Dr. Lindsay Adam
M.D.
Raleigh, NC
Modupe Adetunji
Durham, NC
Dr. Richard Akers
M.D.
Gastonia, NC
Dr. Richard Akers
M.D.
Morganton, NC
Compare Ophthalmology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Paul Riske, MD's specialty? ▼
Paul Riske, MD specializes in Ophthalmology Physician and practices in Raleigh, North Carolina. Credentials: MD.
How much does Paul Riske, MD prescribe under Medicare Part D? ▼
In 2024, Paul Riske, MD wrote 745 Medicare Part D claims totaling $17K in drug costs for 471 beneficiaries.
What is Paul Riske, MD's Medicare quality score? ▼
Paul Riske, MD has a CMS MIPS Final Score of 83.1/100 (Quality: 100, Cost: 49.5). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Paul Riske, MD located? ▼
Paul Riske, MD is located at 2709 BLUE RIDGE RD, Raleigh, NC, 27607. Phone: (919) 782-5400.
What is Paul Riske, MD's NPI number? ▼
Paul Riske, MD's National Provider Identifier (NPI) is 1649477860, issued on 06/29/2007.
Does Paul Riske, MD prescribe more brand-name or generic drugs? ▼
Paul Riske, MD's prescribing is 4% brand-name and 96% generic drugs by claim count, with $9K in brand drug costs.
Does Paul Riske, MD prescribe opioids? ▼
Yes, Paul Riske, MD had 24 opioid claims in 2024 with an opioid prescribing rate of 3.2%.
How many Ophthalmology Physician providers are there in the US? ▼
There are 22,388 Ophthalmology Physician providers across 56 states in the US. The average Ophthalmology Physician provider writes 1,490 Medicare Part D claims per year.
What drugs does Paul Riske, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Paul Riske, MD's most frequently prescribed drugs include Erythromycin, Neomycin-Polymyxin-Dexameth, Moxifloxacin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Paul Riske, MD accept Medicare? ▼
Paul Riske, MD appears in CMS Medicare data with 745 Part D claims and 471 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Paul Riske, MD's credentials? ▼
Paul Riske, MD's NPI is 1649477860 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.